Kelly L. Olson, Ph.D.

Kelly L. Olson, Ph.D.

Salt Lake City, Utah, United States
3K followers 500+ connections

About

Dr. Kelly Olson, is a neuroscientist, author, and keynote speaker who believes that…

Activity

Join now to see all activity

Experience

  • Dr Kelly Olson

    Broomfield, CO

  • -

    Denver, CO

  • -

    Osceola, WI

  • -

    University of Manitoba, Winnipeg, MB Canada

  • -

  • -

    Fort Frances Rainy River District

Education

Licenses & Certifications

  • RPSGT

    -

Volunteer Experience

  • Aboriginal diabetes committee member

    FF/RR Diabetes/Dialysis Committee

    - 1 year

    Health

  • Executive Committee Member

    World Health Organization Safe Communities/RR District Safety Commission

    - 2 years

    Education

    Executive committee member responsible for planning and hosting the World Health Organization Safe Communities conference in Northwestern Ontario. Was also a guest speaker at this conference.

Publications

  • NF-kappaB activated by ER calcium release inhibits Abeta-mediated expression of CHOP protein: enhancement by AD-linked mutant presenilin 1

    Experimental neurology, 2007, Vol.208(2), pp.169-76 [Peer Reviewed Journal]

    Mutations in presenilin which result in early-onset Alzheimer disease (AD) cause both increased calcium release from intracellular stores, primarily endoplasmic reticulum (ER), and changes in NF-kappaB activation. Some studies have also reported that neurons containing AD-linked mutant presenilins (mPS1) show increased vulnerability to various stresses, while others report no differences in neuronal death. The majority of these reports center on potential changes in ER stress, because of the…

    Mutations in presenilin which result in early-onset Alzheimer disease (AD) cause both increased calcium release from intracellular stores, primarily endoplasmic reticulum (ER), and changes in NF-kappaB activation. Some studies have also reported that neurons containing AD-linked mutant presenilins (mPS1) show increased vulnerability to various stresses, while others report no differences in neuronal death. The majority of these reports center on potential changes in ER stress, because of the enhanced ER calcium release seen in mPS1 neurons. One of the primary death effectors of ER stress is CHOP, also termed GADD153, which acts to transcriptionally inhibit protective cellular molecules such as Bcl-2 and glutathione. Because both CHOP and NF-kappaB are activated by increased intracellular calcium and stress, yet have diametrically opposite effects on neuronal vulnerability, we sought to examine this interaction in greater detail. We observed that IP3-mediated calcium release from ER, stimulated by Abeta exposure, mediated both CHOP expression and NF-kappaB DNA binding activity. Further, specific inhibition of NF-kappaB resulted in greater expression of CHOP, while activation of NF-kappaB inhibited CHOP expression. The enhanced release of calcium from IP3-mediated ER stores in mPS1 neurons stimulated increased NF-kappaB compared to normal neurons, which inhibited CHOP expression. Upon blockage of NF-kappaB, exposure to Abeta caused significantly greater Abeta-mediated CHOP expression and death in mPS1 neurons compared to normal neurons. Thus, AD-linked PS1 mutations disrupt the balance between stress-induced NF-kappaB and CHOP, resulting in greater dependence on stress-induced NF-kappaB activation in mPS1 neurons.

    Other authors

More activity by Kelly L.

View Kelly L.’s full profile

  • See who you know in common
  • Get introduced
  • Contact Kelly L. directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses